Diagnosis completeness

Complete and correct diagnosis of failures will account for all observed evidence. In this case, although some questions remain unanswered, it is judged that galvanic corrosion exercised the predominant influence. 

When an antimalarial drug is given to a hospitalized patient for treatment of malaria, the preadministration assessment includes vital signs and a summary of the nature and duration of the symptoms. Laboratory tests may be ordered for the diagnosis of malaria Additional laboratory tests, such as a complete blood count, may be ordered to determine the patient s general health status. 

This drug is used for complete or partial reversal of narcotic depression, including respiratory depression. Narcotic depression may be due to intentional or accidental overdose (self-administration by an individual), accidental overdose by medical personnel, and drug idiosyncrasy Naloxone also may be used for diagnosis of a suspected acute opioid overdosage. 

The nurse obtains the vital signs at die time of the initial assessment to provide baseline data. The primary healtii care provider may order many laboratory and diagnostic tests, such as an electroencephalogram, computed tomographic scan, complete blood count, and hepatic and renal function tests to confirm the diagnosis and identify a possible cause of the seizure disorder, as well as to provide a baseline during therapy with anticonvulsants. 

Study of the transport of substances across membranes is an example. There is considerable knowledge of the transport of small molecules across living membranes this should be extended to studies of larger molecules. A more complete understanding of the transport of biologically active agents would be particularly important in diagnosis and therapy. 

A complete history should be obtained so that the patient s symptoms can be evaluated and the diagnosis of constipation confirmed. The diagnosis of constipation is suggested by fewer than three bowel movements per week, consistency of hard lumpy stool, excessive straining, prolonged defecation time, or need to support the perineum or digitally manipulate the anorectum. 

Transection or severing of the axon disrupts nerve signals completely and irreversibly.8 There is growing evidence that cytotoxic (CD8+) T cells cause axonal injury.5 Axonal transection begins as early as 2 weeks after diagnosis and continues throughout the course of the disease.9... 

Criteria for diagnosis Five or more attacks fulfilling the above criteria are necessary for diagnosis Laboratory assessments that may be helpful in excluding medical comorbidities Complete blood cell count (CBC), chemistry panel, thyroid function tests, erythrocyte sedimentation rate (ESR)... 

Splenectomy generally is considered after 3 to 6 months if the patient continues to require 10 to 20 mg/day of prednisone to keep the platelet count greater than 30,000/mm3 (30 x 103/jliL or 30 X 109/L) or within 6 weeks of diagnosis in patients with platelet counts of less than 10,000/mm3 (10 x 103/ju,L or 10 x 109/L) despite treatment. Even though individual patient response cannot be predicted, approximately two-thirds of refractory patients have a favorable response to splenectomy within a couple of days. After splenectomy, approximately 85% of adults attain a stable hemostatic response, and 70% to 80% of children attain complete remission. Within 5 to 10 years, approximately 25% of responding adult patients relapse. Laproscopic splenectomy is preferable to open splenectomy because it speeds the recovery and shortens the duration of hospitalization. The major drawback of splenectomy is bacterial sepsis, occurring at incidence rates of about 1%. 

Early breast cancer is resected completely with curative intent, and adjuvant chemotherapy and hormonal therapy are initiated to prevent recurrence. During adjuvant chemotherapy, laboratory values to monitor chemotherapy toxicity are obtained prior to each cycle of chemotherapy. After completion of adjuvant therapy, patients are monitored every 3 months for the first few years after diagnosis, with intervals between exams extended as time from diagnosis lengthens. 

Allogeneic hematopoietic stem cell transplantation (HSCT) has been used in the treatment of pediatric AML in first complete remission. In most clinical trials, the availability of HLA-matched sibling donors determined whether patients underwent HSCT as postremission treatment. To facilitate this process, it is important to obtain HLA typing on all younger patients with AML and siblings shortly after diagnosis. Patients who do not have an HLA-matched sibling will proceed to postremission therapy. 

The limit of detection of the assay was estimated to be 200 parasites/ml of blood. The detection limit is well within the range of sensitivity needed to diagnosis trypanosomiasis, as the parasitemia may vary from 5000 to 1,500,000 parasites/ml (Vickerman, 1974). The bDNA assay was compared with buffy coat microscopy for detection of T brucei in 56 blood samples (36 buffy coat positive and 20 buffy coat negative by microscopy). There was complete concordance between the results of the two tests in terms of identifying specimens as positive of negative. However, the numbers of parasites observed by microscopy were lower overall than those calculated with the bDNA assay. The authors suggested that the excess of leukocytes in the buffy coat could interfere with the microscopic detection of typanosomes, resulting in lower apparent parasitemia than the true value. 

The complete four-component system is necessary when the diagnostic requirement is rapid, low unit-cost analysis for both the strain-level characterization of pathogenic agents and identification of hoax bio-terror materials. Using the complete system, we are proposing to validate MS-based microbial taxonomy and to transfer the technology from an analytical research to a clinical or public health production-diagnosis environment. 

The need for and ethics of cancer therapy with radiopharmaceuticals are now being carefully discussed. The success in diagnosis of cancer using "Tc has provoked interest in the possibility of cancer therapy with radiorhenium. Even if complete recovery from the disease has not yet been achieved, positive changes in the quality of life (in about 80% of all patients) were reported by rhenium treatment for bone metastases. 

---